First scientific presentation of beforehand introduced information from Cohort 1 of the continuing Section 1b medical trial evaluating low-dose LTI-03…
SYNERGY-NASH outcomes had been introduced on the European Affiliation for the Research of the Liver Congress 2024 and concurrently revealed…
Our selection of the week's biggest research news and features sent directly to your inbox. Enter your email address, confirm you're happy to receive our emails.
Please contact salesdepartment
for further information at:
Sales@88.broker
Sign in to your account